Iq-ai Share Discussion Threads

[spurs90] 28/3/2020 08:32

Posted by Iqai on Twitter

Prayers and best wishes to all those affected - especially those on the front lines! Fortunately, IQAI's operations continue - by virtually conducting product demos to clients, developing product, providing training, and growing!

[turbotrader2] 27/3/2020 19:05

This will fly soon WATCH

[chinadog3] 27/3/2020 08:35

Stonechecker?

[phurley] 27/3/2020 08:32

Might double - a very leaky ship this one

[phurley] 27/3/2020 08:20

Looks like massive news coming here

[dplewis1] 23/3/2020 11:37

Clang..! Into the 1's for Top Plop Stocks and his terrible tips!

[formula1187] 22/3/2020 17:46

I think your right maybe, AI imaging ramping up FACT!!!

[formula1187] 22/3/2020 11:07

AI imaging! Time to top up there maybe a link to to with covid testing !

[hulk2004] 20/3/2020 07:15

Excellent RNS, IB software being validated by recognised professionals in the medical world, IB has huge potential and if they can push this through to income which I believe will happen then this can be sold for a lot of cash! Still think this will be sold within next 12 months so a bit of a waiting game, company results next month will be interesting, stay safe everyone!

[dplewis1] 18/3/2020 15:47

Lol..desperate ramping from Top Plop Stocks and the usual reaction - RED!

[onceatrader] 18/3/2020 15:25

Giulia Bottaro
15:04 Wed 18 Mar 2020

Investor deep dive
StoneChecker approval fires up medical imaging diagnostics specialist IQ-AI

read more >
viewIQ-AI Limited
IQ-AI says Imaging Biometrics’ software features in award-winning research paper
The article was published in the March 2020 issue of the American Journal of Neuroradiology, which recognised it as the best original research paper accepted in 2019

IQ-AI Limited - IQ-AI says Imaging Biometrics’ software features in award-winning research paper
IQ-AI Limited (LON:IQAI) said its Imaging Biometrics (IB) subsidiary, a provider of ready-to-use software to the healthcare industry, had its software featured in the top-award-winning article of a paper.

IB’s product is a vascular mapping software able to identify and distinguish recurrent high-grade brain tumour from benign treatment effects.

READ: IQ-AI says Imaging Biometrics subsidiary enlists university professor
The article was published in the March 2020 issue of the American Journal of Neuroradiology, which assigned it the Lucien Levy Award, recognising it as the best original research paper accepted in 2019.

“Our relative cerebral blood volume maps have the potential to aid clinical decision-making before surgery, during recovery, and during follow-up treatment,” said Michael Schmainda, chief executive of IB.

“This optimised workflow certainly has the potential of becoming the consensus methodology, as the paper cites.”

Shares advanced 5% to 2.2p on Wednesday afternoon.

[dave4545] 18/3/2020 15:16

lol

How old is that link smallcappick

[onceatrader] 18/3/2020 15:14

Giulia Bottaro
15:04 Wed 18 Mar 2020
[...]


IQAI 12 month price target expects IQ-AI Ltd share price to rise to 63.25 in the next year from the last price of 2.10. +2,911.9%

[spurs90] 18/3/2020 14:46

Rns

Study Using Imaging Biometrics' Brain Tumor Image Analysis Software Wins 2019's Top Award from the American Journal of Neuroradiology

[spurs90] 18/3/2020 11:26

100k buys showing from yesterday after hours